Avidity Biosciences
RNA
#3239
Rank
S$4.54 B
Marketcap
$37.80
Share price
1.26%
Change (1 day)
14.92%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of December 2024 : S$1.96 Billion

According to Avidity Biosciences's latest financial reports the company has S$1.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$2.04 B159.57%
2023-12-31S$0.78 B-3.96%
2022-12-31S$0.81 B49.34%
2021-12-31S$0.54 B26.29%
2020-12-31S$0.43 B240.46%
2019-12-31S$0.12 B2920.52%
2018-12-31S$4.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.49 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.25 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.77 B-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.67 B-65.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.36 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.79 B 1,263.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.09 B 210.40%๐Ÿ‡ฌ๐Ÿ‡ง UK